Schedule II-Condensed Financial Information of Registrant - Statement of Comprehensive Income (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2025	Dec. 31, 2024	Dec. 31, 2023
Condensed Financial Statements, Captions [Line Items]
Shareholders' net income	$ 5,662	$ 5,980	$ 5,987
Other comprehensive income (loss), net of tax:
Change in net unrealized gains/losses on investments	633	103	1,117
Change in non-credit component of impairment losses on investments	1	(1)	0
Change in net unrealized gains/losses on cash flow hedges	8	4	18
Change in net periodic pension and other benefit costs	67	60	40
Change in future policy benefits	(3)	(2)	(3)
Foreign currency translation adjustments	(4)	(6)	(1)
Total shareholders’ comprehensive income	6,358	6,146	7,164
Elevance Health, Inc.
Condensed Financial Statements, Captions [Line Items]
Shareholders' net income	5,662	5,980	5,987
Other comprehensive income (loss), net of tax:
Change in net unrealized gains/losses on investments	629	109	1,123
Change in non-credit component of impairment losses on investments	(1)	1	0
Change in net unrealized gains/losses on cash flow hedges	8	4	18
Change in net periodic pension and other benefit costs	67	60	40
Change in future policy benefits	(3)	(2)	(3)
Foreign currency translation adjustments	(4)	(6)	(1)
Other comprehensive (loss) income	696	166	1,177
Total shareholders’ comprehensive income	$ 6,358	$ 6,146	$ 7,164